Theralase Technologies files unaudited Q2 2026 results; Phase II update
Theralase Technologies Inc. released unaudited interim consolidated financial statements for the six months ended June 30, 2026 and provided updates on its Phase II NMIBC study.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.